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Background: The HORIZONS-AMI trial demonstrated that bivalirudin alone
(BIV), compared to heparin plus a glycoprotein IIb/IIIa inhibitor (GPI), resulted
in signiﬁcantly reduced rates of major bleeding and increased event-free survival
in patients with acute STEMI undergoing primary PCI. However, the
additional impact of femoral vascular closure devices (VCD) on bleeding complica-
tions and net adverse clinical events (NACE) in this STEMI population has not been
reported.
Methods: The HORIZONS-AMI trial enrolled 3602 STEMI patients of whom
3360 patients underwent femoral access. The 2 primary 30-day endpoints were non-
CABG-related major bleeding and NACE (major bleeding or major adverse cardiac
events [MACE: death, reinfarction, target-vessel revascularization for ischemia, and
stroke]). Bleeding was also assessed using TIMI and GUSTO scales. This post-hoc,
subgroup analysis reports these endpoints at 30-day and 1-year follow-up, comparing
VCD with no VCD and randomization to BIV and UFH + GPI.
Results: VCDs were used in 982 (29.2%) patients and not used in 2378 (70.8%)
patients. Patients treated with a VCD who were also randomization to BIV had
signiﬁcantly reduced 30-day rates for non-CABG related major bleeding, TIMI and
GUSTO bleeding, MACE and NACE compared to no VCD and UFH + GPI (Figure).
These results persisted at 1-year follow-up. Multivariate analysis revealed a 30-day
hazard ratio [95% CI] of 0.71 [0.53, 0.95] p¼0.02 for major (non-CABG) bleeding
and 0.58 [0.45, 0.74] p<0.001 for NACE with VCD use.Conclusions: Use of a VCD and randomization to BIV resulted in reduced bleeding
complications and increased event-free survival in this STEMI population.
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Background: Trans-radial access (TRA) for invasive coronary assessment and
percutaneous coronary intervention (PCI) has evolved as an alternative default
strategy for vascular access to the femoral approach, and in many centers is used more
frequently than femoral access. One of the barriers to more widespread adoption of
TRA is achieving successful cannulation of the radial artery, both in a timely fashion,
and with minimal needle passes so as to reduce the rate of arterial spasm. We sought toJACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT Abstrassess the value of using real-time ultrasound (RTUS) guidance to improve these
parameters.
Methods: We performed a prospective, single center study of consecutive patients
presenting for invasive coronary angiography (or PCI) via the trans-radial approach.
The ﬁrst phase of the study enrolled consecutive patients who underwent TRA without
the assistance of RTUS followed by consecutive patients who underwent TRA using
RTUS guidance. The primary outcome measure was the time between commencing
needle attempts for arterial access and sheath insertion. Other outcome measures were
number of needle passes through the skin to achieve arterial access and number of
artery punctures to secure access with wire and sheath.
Results: 200 consecutive patients were studied. 100 consecutive patients underwent
TRA without RTUS guidance followed by 100 patients with RTUS assistance. There
were no statistically signiﬁcant differences in any of the outcome measures. Mean
time between commencing needle attempts for arterial access to sheath insertion with
no RTUS guidance was 153 seconds (95% CI 115 – 190 seconds) versus 132 seconds
(95% CI 100 – 163 seconds) with RTUS, p¼0.55. Mean number of needle passes
through the skin required with no RTUS guidance was 3.2 (95% CI 2.3 – 4.1) versus
2.57 (95% CI 2.0 – 3.1) with RTUS, p¼0.15. Mean number of arterial punctures with
no RTUS guidance was 1.1 (95% CI 1.0 – 1.2) versus 1.2 (95% CI 1.1 – 1.3) with
RTUS, p¼0.12.
Conclusions: Use of RTUS guidance to assist in TRA did not signiﬁcantly reduce
time to vascular access or the number of access attempts required. Our study does
not support the routine use of ultrasound in obtaining vascular access via radial
approach.TCT-294
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Background: The safety and efﬁcacy of two-stent implantation through transradial
(TR) versus transfemoral (TF) approach for treatment of true bifurcation lesions have
not been investigated. The study intended to compare the immediate and long-term
outcomes of two-stent strategy between TR and TF percutaneous revascularization in
this complex coronary anatomy.
Methods: Among 805 consecutive patients with true bifurcation lesions treated with
two-stent implantation via either TR (n¼508) or TF (n¼297) approach from April
2004 to April 2009 at our center were analyzed retrospectively. The baseline,
procedural outcomes, angiographic characteristics, in-hospital, and long-term clinical
events were compared according to vascular approach method.
Results: The demographic, clinical, procedural, and angiographic characteristics
were similar between groups, except less prior percutaneous coronary intervention
and left main bifurcation disease in TR group compared to TF group (all p<0.05).
The duration of hospital stay (7.10  4.17 days vs. 9.32  5.57 days, p<0.0001)
and in-hospital occurrence of Bleeding Academic Research Consortium (BARC)
deﬁned bleeding (3.9% vs. 9.1%, p<0.01) were signiﬁcantly lower in TR group.
Using logistic regression to derive the propensity score model, 249 matched pairs of
patients were compared. During a mean follow-up period of 5522 months, in
a multivariate regression analysis, TR method was not predictive of major adverse
cardiac events (adjusted hazards ratio [HR]: 1.33, 95% conﬁdence interval [CI]:
0.83-2.14), cardiac death (adjusted HR: 0.67, 95% CI: 0.11-3.99), myocardial
infarction (adjusted HR: 1.43, 95% CI: 0.82-2.50), target vessel revascularization
(adjusted HR: 0.93, 95% CI: 0.45-1.93), and stent thrombosis (adjusted HR: 0.56,
95% CI: 0.19-1.66).
Conclusions: In contrast to TF vascular access, two-stent implantation via TR
approach for true bifurcation lesions is feasible and associated with similar in-hospital
outcomes, abbreviated hospitalization, reduced bleeding, and comparable long-term
clinical safety and efﬁcacy.
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Background: Rotational Atherectomy (RA) is a well established adjuvant device for
use during Percutaneous Coronary Intervention (PCI). The femoral artery has
historically been the arterial access of choice for RA, facilitating the use of large-bore
guide catheters. Transradial access has become a default for many European centres,
but the use of RA has previously been limited. We present a large, contemporary,
multicentre comparison RA PCI via the radial and femoral routes.
Methods: Patients from three regional cardiology centres from the United Kingdom
undergoing RA PCI from 2008 to 2012 were included in the study. Patients wereacts/POSTER/Vascular Access and Closure B95
